Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review

June 2021 | 59 pages | ID: S449011145DEN
GlobalData

Abstracts

Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shionogi & Co Ltd (Shionogi) focuses on the research, development, manufacturing and marketing of pharmaceutical products, diagnostic reagents and medical devices. The company offers prescription drugs, over the counter (OTC) drugs and diagnostic products for the therapeutic areas including metabolic disorders, infectious diseases, pain/central nervous system (CNS) and cancer. The company operates a network of subsidiaries, branches, sales offices manufacturing plants and research laboratories across Japan, China, Taiwan in Asia; North America and Europe. Shionogi is headquartered in Osaka, Japan.

Shionogi & Co Ltd Key Recent Developments

Apr 27,2021: InveniAI and Shionogi enter AI-powered multi-target drug discovery collaboration
Feb 24,2021: Shionogi announces corporate reorganization and personnel reassignment
Feb 19,2021: Shionogi wins the “Environmental Report Excellence Award” for its Integrated Report/Environment Report at the “Environmental Communication Awards”
Feb 01,2021: Shionogi: Consolidated financial results for the third quarter of fiscal year 2020
Dec 25,2020: Award of the EPC Contract for a producing facility of a Vaccine Drug Substance from Shionogi & co

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Shionogi & Co Ltd - Key Facts
Shionogi & Co Ltd - Key Employees
Shionogi & Co Ltd - Key Employee Biographies
Shionogi & Co Ltd - Major Products and Services
Shionogi & Co Ltd - History
Shionogi & Co Ltd - Company Statement
Shionogi & Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Shionogi & Co Ltd - Business Description
R&D Overview
Shionogi & Co Ltd - Corporate Strategy
Shionogi & Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Shionogi & Co Ltd - Strengths
Shionogi & Co Ltd - Weaknesses
Shionogi & Co Ltd - Opportunities
Shionogi & Co Ltd - Threats
Shionogi & Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Shionogi & Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 27, 2021: InveniAI and Shionogi enter AI-powered multi-target drug discovery collaboration
Feb 24, 2021: Shionogi announces corporate reorganization and personnel reassignment
Feb 19, 2021: Shionogi wins the “Environmental Report Excellence Award” for its Integrated Report/Environment Report at the “Environmental Communication Awards”
Feb 01, 2021: Shionogi: Consolidated financial results for the third quarter of fiscal year 2020
Dec 25, 2020: Award of the EPC Contract for a producing facility of a Vaccine Drug Substance from Shionogi & co
Aug 07, 2020: Shionogi to announce personnel reassignment
Aug 07, 2020: Shionogi announces commitment to fight COVID-19 (4)
Jun 22, 2020: Shionogi to develop detection device for infectious diseases
Jun 22, 2020: Japan's Shionogi partners with universities to develop visual coronavirus test
Jun 03, 2020: Shionogi announces commitment to fight COVID-19 (2)

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Shionogi & Co Ltd, Key Facts
Shionogi & Co Ltd, Key Employees
Shionogi & Co Ltd, Key Employee Biographies
Shionogi & Co Ltd, Major Products and Services
Shionogi & Co Ltd, History
Shionogi & Co Ltd, Other Locations
Shionogi & Co Ltd, Subsidiaries
Shionogi & Co Ltd, Joint Venture
Shionogi & Co Ltd, Key Competitors
Shionogi & Co Ltd, Ratios based on current share price
Shionogi & Co Ltd, Annual Ratios
Shionogi & Co Ltd, Annual Ratios (Cont...1)
Shionogi & Co Ltd, Annual Ratios (Cont...2)
Shionogi & Co Ltd, Interim Ratios
Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Shionogi & Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Shionogi & Co Ltd, Performance Chart (2017 - 2021)
Shionogi & Co Ltd, Ratio Charts
Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021